Title

Bleeding Risk with Rivaroxaban, Enoxaparin, and Aspirin Following Total Joint Arthroplasty or Revision

Division

Continental

Hospital

Sky Ridge

Document Type

Poster

Publication Date

4-5-2019

Keywords

intraoperative complications, venous thromboembolism, VTE, total joint arthroplasty, postoperative prophylaxis, bleeding risk

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Internal Medicine | Medicine and Health Sciences | Pathological Conditions, Signs and Symptoms

Abstract

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially fatal byt preventable complication of orthopedic surgery. Following surgery, patients are routinely started on prophylactic oral or pareteral anticoagulation. Standard medicaions used in this setting include enoxaparin, low-dose ungractionated heparin, vitamin K antagonists, fondaparinux, apixaban, dabigatran, rivaroxaban, and aspirin. A major risk when using these medications is bleeding and must be considered when choosing among them.

Publisher or Conference

Rocky Mountain Healthcare Symposium

This document is currently not available here.

Share

COinS